Filing Details

Accession Number:
0000947871-23-000687
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-06-20 16:33:04
Reporting Period:
2023-06-16
Accepted Time:
2023-06-20 16:33:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1408100 Kennedy-Wilson Holdings Inc. KW Fire, Marine & Casualty Insurance (6331) Z4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
915191 Can Ltd/ Holdings Financial Fairfax 95 Wellington Street West
Suite 800
Toronto A6 M5J 2N7
Yes No Yes No
938869 Al Et Prem V Watsa 95 Wellington Street West
Suite 800
Toronto A6 M5J 2N7
Yes No Yes No
1217251 Sixty Two Investment Co Ltd 1600 Cathedral Place
925 West Georgia St
Vancouver A1 V6C 3L3
Yes No Yes No
1275993 Ltd. Holdco 1109 Second 95 Wellington Street West
Suite 800
Toronto A6 M5J 2N7
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
6.00% Series C Cumulative Perpetual Preferred Stock Acquisiton 2023-06-16 200,000 $0.00 200,000 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrants Acquisiton 2023-06-16 12,338,062 $0.00 12,338,062 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
12,338,062 No 4 P Indirect
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 13,322,009 Indirect See Footnote
Footnotes
  1. On June 16, 2023, wholly-owned subsidiaries of Fairfax Financial Holdings Limited ("Fairfax"), purchased 200,000 shares of the Issuer's 6.00% Series C Cumulative Perpetual Preferred Stock ("Preferred Stock") and warrants (the "Warrants") to purchase 12,338,062 shares of the common stock of the Issuer, for an aggregate purchase price of $200,000,000.
  2. The Warrants may be exercised at any time, in whole or in part, for seven years from the date of issuance at an exercise price per Warrant of $16.21, subject to anti-dilution adjustment. Upon exercise of any Warrants, the holder of such Warrants has the right to reduce the cash amount to be paid with respect to the exercise price of the Warrant on a dollar-for-dollar basis by requiring the Issuer to instead extinguish shares of Preferred Stock held by such holder (using a value of $1,000 per share of Preferred Stock plus accrued and unpaid dividends) equal to up to the aggregate exercise price for such exercised Warrants.
  3. Holders of Preferred Stock are entitled to receive cumulative cash dividends from the Issuer, payable quarterly on the $1,000 per share liquidation preference of the Preferred Stock, at a rate of 6.00% per annum. The Preferred Stock has no expiration date but may be redeemed at any time by the Issuer, at its option, in whole or in part, for cash.
  4. These securities are held by subsidiaries of Fairfax. Mr. Watsa is the CEO and controlling person of Fairfax through the other reporting persons. Each of the reporting persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the reporting persons is a beneficial owner for the purpose of Section 16 of the Exchange Act, or for any other purpose.